Iodine deficiency in the world and in the Czech Republic – current status and perspectives

Czech version

Authors: V. Zamrazil ^1,2; R. Bílek ¹; J. Čeřovská ¹; M. Dvořáková ¹; J. Němeček ¹
Authors‘ workplace: Endokrinologický ústav Praha, ředitel doc. MU Dr. Vojtěch Hainer, CSc. 2 Subkatedra endokrinologie IPVZ Praha, vedoucí pracoviště prof. MU Dr. Václav Zamrazil, DrSc. ¹
Published in: Vnitř Lék 2010; 56(12): 1310-1315
Category: Celebration

Overview

Iodopenia is importance world- wide problem – the cause of spectrum of iodine deficiency disorders (IDD). The “simple” way for its compensation is iodine supplementation – preferably by iodinization of salt: in the Czech Republic prevalence of IDD was very high in the past. The complex program for compensation of iodine deficiency realized in the CR includes improvement of salt iodization, supplementation of pregnant and lactating women, fortification of products for babies’ nutrition and increasing use of iodinized salt in general population incl. food industry. Thus CR is country with compensated iodine deficiency according to criteria WHO, UNICEF, ICCIDD. In future, however, systematic interest should be focused on optimalization of iodine saturation, esp. in pregnant women and evaluation of possible risk of supranormal iodine intake (impairment of thyroid function, activation of thyroid autoimmunity). Taking in account, the changes of nutrition and life style systematic monitoring of quality of iodine supplementation seems to be essential.

Key words:
iodine – the thyroid – iodine deficiency disorders – ioduria – iodopenia in pregnancy – thyroid autoimmunity

Sources

1. Abalovich M, Amino N, Barbour LA et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2007; 92 (Suppl 8): S1– S47.

2. Azzizi F. Iodine deficiency Disorders: silent pandemia. Thyroid Int 2009; 4: 1– 11.

3. Bílek R, Zamrazil V. Thyroblobulin as an indicator of iodine intake. In: Preedy VE et al (eds). Comprehensive handbook of iodine. Oxford: Academic Press 2009.

4. Čeřovská J, Bílek R, Zamrazilová H et al. Změny zásobení jodem české dospělé populace po eradikaci jodového deficitu a jejich příčiny. Randomizovaná studie dospělé populace 2 regionů Ceské republiky s odstupem 5 let. Vnitř Lék 2006; 52: 858– 863.

5. DeCamargo RA, Tomimori E. Risk of iodine excess in Brazil. Brazil: IDD Newsletter 2009; 31: 7.

6. Delange F. Optimal iodine saturation during pregnancy, lactation and neonatal period. Int J Endocrinol Metab 2004; 89: 1– 12.

7. Delange F, Bürgi H, Chen ZP et al. World status of monitoring iodine deficiency disorders control programs. Thyroid 2002; 12: 915– 924.

8. Dvořáková M, Bílek R, Hill M et al. Volumy štítné žlázy u dospělé populace ve věku 18– 65 let v České republice – stanovení norem. Vnitř Lék 2006; 52: 57– 63.

9. Glinoer D. Pregnancy and iodine. Thyroid 2001; 11: 471– 481.

10. Hetzel BS. The role of the ICCIDD in the global program for the elimination of brain damage due to iodine deficiency. In: Preedy VE et al (eds). Comphrehansive handbook of iodine. Oxford: Academic Press 2009: 724– 730.

11. Hollowell JG, Staehling NW, Hannon WH et al. Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971– 1973 and 1988– 1994). J Clin Endocrinol Metab 1998; 83: 3401– 3408.

12. Kahaly GJ, Dienes HP, Beyer J et al. Iodine induces thyroid autoimmunity in patients with endemic goitre: a randomised, double‑blind, placebo– controlled trial. Eur J Endocrinol 1998; 139: 290– 297.

13. Laurberg P, Pederssen IB, Carlé A et al. The U– Shapperd Curve of iodine intake and thyroid disorders. In: Preedy VE et al (eds). Comprehensive handbook of iodine. Oxford: Academic Press 2009: 449– 455.

14. Laurberg P, Pedersen IB, Carlé A et al. Surveillance of thyroid disorders and iodine fortification of salt. The Danthyr Program. In: Preedy VE et al (eds). Comprehensive handbook of iodine. Oxford: Academic Press 2009.

15. Manner V, Werley A. Achieving and sustaing universal salt iodization reflecting an issues and stategies. IDD Newsletter 2010; 37: 13– 17.

16. Milne J, Cannerosi C. New Zealand pregnant women offered new iodine supplement. IDD Newsletters 2010; 37: 9– 10.

17. Pearce EN, Gerber AR, Gootnick DB et al. Effects of chronic iodine excess in cohort of long‑term American workers in West Africa. J Clin Endocrinol Metab 2002; 87: 5499– 5502.

18. Perrine C, Herrick K, Serdula M et al. Some subgroups of Reproductive age women from the United States may be at risk of iodine deficiency. IDD Newsletter 2010; 37: 5– 6.

19. Iodine deficiency during pregnance. IDD Newletter 2010; 37: 1.

20. WHO: Assessment of the iodine deficiency disorders and monitoring their delimination, a guide for programme managers. Report of Consultation. May 4– 6, Geneva 1999.

21. WHO: Technical consultation of experts in Geneva in Year 2005. The prevention and control of ID in pregnant and lactating women and children under two years. Recommendation of a WHO Technical consultation. Publ Health Nutr 2007.

22. Zamrazil V, Čeřovská J, Bílek R et al. Hodnocení výsledků jodové profylaxe v České republice. Čas Lék Čes 2007; 146: 262– 266.

23. Zamrazil V, Bílek R, Čeřovská J et al. The elimination of iodine deficiency in Czech republic: the steps toward success. Thyroid 2004; 14: 49– 56.

24. Zamrazil V, Dvořáková M. Nemoci štítné žlázy a zdravotní stav populace. Lék Listy 2009; 16: 12– 15.

25. Zamrazil V, Bílek R, Čeřovská J et al. Evaluatin of iodine prophylaxis in the Czech Republic. Changed in ioduria, thyroid status and autoimmunity. In: Preedy VE et al (eds). Comprehensive handbook of iodine. Oxford: Academic Press 2009: 835– 845.

26. Zois C, Stavrou I, Kalogera C et al. High prevalence of autoimmune thyroiditis in schoolchildren after elimination of iodine deficiency in northwestern Greece. Thyroid 2003; 13: 485– 489.